Breaking News
Just Get Out! Now!
THE WEAPONIZATION OF GOVERNMENT AGAINST IT'S PEOPLE
Trump Begs For Help On Hormuz; World Says 'No.:
American begins drafting Gen Z to fight in war against Iran
Top Tech News
Musk Whips Out 'Macrohard' In Disruptive Tesla-xAI Bid To Shaft Software Companies
This Bonkers Folding X-Plane Is One Step Closer to Hitting the Skies
Smart 2-in-1 digital microscope goes desktop or handheld as needed
Human Brain Cells Merge With Silica To Play DOOM
Will Yann LeCun Provide The Next Breakthrough In AI?
Human Brain Cells Merge With Silica To Play DOOM
Solar And Storage Could Reshape Rural Electricity Markets
With World Seemingly At War, DARPA Finds Time To Unveil The X-76
Renewable Water From Air.
The world's first diesel plug-in hybrid pickup truck is here
New psychedelic-like drug boosts the body's 'feel good' hormone WITHOUT hallucinations -
'AAZ-A-154' is an overlooked molecule that could provide mental health therapy
It stimulates receptors for serotonin, which mediates satisfaction and happiness
In trials on mice it produced rapid and 'long-lasting antidepressant-like effects'
A newly-identified 'psychedelic-like drug' doesn't cause hallucinogenic side effects, scientists reveal.
AAZ-A-154 is a 'previously unstudied' molecule that has the potential to act on beneficial pathways in the brain without causing hallucinations.
It stimulates receptors for serotonin – a key hormone sent between nerve cells in our brain that stabilises our mood, well-being and happiness.
In experiments on mice, AAZ-A-154 produced rapid and long-lasting antidepressant-like effects after a single dose, the US researchers found – and, if synthesised, could be an effective treatment for humans.
Psychedelic drugs have already shown promise for treating neuropsychiatric disorders such as depression and post-traumatic stress disorder (PTSD).
Researchers are now trying to identify alternative medications that offer the benefits of psychedelics without causing often distressing hallucinations.